TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30. (September 2022) - Gerlach, M; Schmitt, S; Cyprys, P; Kasper, M-A; Mai, I; Vermeer, MH; Horwitz, SM; Fingerle-Rowson, G; Vogl, A; Schumacher, D; Helma-Smets, J